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The vaccinia virus gene A38L encodes a highly hydrophobic protein with amino acid similarity to mammalian integrin-
associated protein (IAP). In this report we have identified the A38L protein of strain Western Reserve (WR), defined its
membrane topology, and analyzed its role in virus production and virulence. An antiserum raised against an A38L peptide
identified the A38L gene product as a 33-kDa protein which is expressed at low levels during virus infection. A serum from
a rabbit previously infected with WR virus recognized the A38L protein, thus confirming that the A38L gene is expressed
in vivo. Using a coupled in vitro-translation/membrane-translocation system the 33-kDa protein was shown to be a membrane-
associated and glycosylated form of a 29-kDa polypeptide precursor. The membrane topology of the A38L protein was
defined by its glycosylation and protease sensitivity when associated with microsomal membranes. The N-terminal immuno-
globulin-like variable domain was protected from exogenous protease and was therefore in the lumen of the vesicle, whereas
the C-terminus was sensitive and therefore cytoplasmic. A38L deletion and revertant viruses were constructed and were
used to study the involvement of A38L in virus assembly, release, and virulence. Deletion of the A38L gene caused a slight
reduction in virus plaque size but did not affect the production of intracellular mature virus or extracellular enveloped virus
particles in tissue culture cells nor the virulence of the virus in the murine intranasal model. The A38L protein therefore
possesses similar sequence and membrane topology to the mammalian IAP protein but is not required for virus particle
production or virulence. q 1995 Academic Press, Inc.
INTRODUCTION predicted to be encoded by the gene A38L, formerly
called SalL8L in the WR strain (Smith et al., 1991). This
Vaccinia virus is a large complex DNA virus of the ORF is highly conserved between vaccinia strains WR
family Poxviridae. The virus replicates within cytoplasmic (Smith et al., 1991) and Copenhagen (Goebel et al., 1990)
viral factories (Moss, 1990) and undergoes a complex (97.5% amino acid identity) and between vaccinia strain
process of morphogenesis to produce two distinct forms WR and the corresponding ORF of the Harvey (Aguado
of infectious particles. Virion assembly is initiated when et al., 1992), Bangladesh-1975 (Massung et al., 1993),
crescent-shaped membranes, which are derived from the and India-1967 (Shchelkunov et al., 1994) strains of vari-
intermediate compartment, envelope areas of granular ola major virus (94.9% amino acid identity). The vaccinia
viroplasm to form intracellular mature virus (IMV) parti- virus A38L protein has 28% amino acid identity with the
cles (Sodeik et al., 1993). A fraction of these IMV particles mammalian integrin-associated protein (IAP) (Lindberg
then undergoes further morphogenesis events to form et al., 1993), also known as OA3 (Campbell et al., 1992),
extracellular enveloped virus (EEV) which is released and the Rh-associated 1D8 antigen CD47 (Lindberg et
from the cell, although with strain Western Reserve (WR) al., 1994). IAP binds to b3 integrins and is required both
the majority of EEV is found attached to the cell surface for integrin–ligand interaction (Brown et al., 1990) and
as cell-associated enveloped virus (CEV) (Blasco and for integrin-mediated Ca2/ entry into cells (Schwartz et
Moss, 1992). al., 1993).
The 191-kb genome of vaccinia virus strain Copenha- Although the level of amino acid identity (28%) in the
gen (Goebel et al., 1990) and over 95% of the genome of N-terminal immunoglobulin-variable (IgV)-like domain of
strain WR (Smith et al., 1991; and Refs. therein) have vaccinia virus A38L and IAP is not above that seen be-
been sequenced. These viruses contain approximately tween distantly related members of the Ig superfamily
200 open reading frames of which only a proportion have (IgSF), this level of similarity extends across the entire
been functionally characterized (Johnson et al., 1993). length of the proteins, and the molecules have very simi-
Several of the uncharacterized vaccinia proteins have lar hydrophobicity profiles. These molecules represent
interesting amino acid similarities to functionally defined most of the rare examples of proteins which contain an
mammalian proteins. One such example is the protein IgSF domain linked to multiple membrane-spanning se-
quences [another example is the polycystic kidney dis-
ease 1 protein which possesses 16 IgSF domains, a C-1 To whom reprint requests should be addressed. Fax: 44-1865-
275501. E-mail: glsmith@molbiol.ox.ac.uk. type lectin domain, 4 fibronectin type III domains, and 11
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transmembrane domains (Hughes et al., 1995)]. Given duced. To create pJEP7, a 1307-bp AluI fragment con-
taining the complete A38L gene was removed from pJEP1the observed similarities between the A38L gene of vac-
cinia and the mammalian IAP protein, it is possible that and ligated into the SmaI site of pUC119 forming pJEP3.
A 215-bp region of the 5* end of A38L was removed byboth the structure and the function of the two proteins
could be conserved. It may therefore be possible to de- SpeI and EcoRI digestion of pJEP3 and was replaced
with a polymerase chain reaction (PCR) product of thetermine the function of the A38L gene by extrapolation
from the known structure and functional properties of the 5* end of A38L. This PCR product was formed using an
oligonucleotide complementary to the 5* end of A38L andIAP protein (Campbell et al., 1992; Lindberg et al., 1993).
In this paper, a characterization of the WR A38L protein containing additional 5* EcoRI (5*), BamHI, and NcoI (3*)
restriction enzyme sites (5*CCCGAATTCGGATCCACC-is described, and the role of this protein in the virus life
cycle is addressed by the construction of deletion mutant ATGGGCATGTCAAGAGTTAGAATA) and a 3* oligonucle-
otide complementary to sequences spanning the SpeIand revertant viruses.
site of A38L (nucleotides 223–206) (5*GTCTAGCACTAG-
TATGCC). The fidelity of the PCR sequence was con-MATERIALS AND METHODS
firmed by sequencing. The modified A38L gene in the
Cells and viruses resultant plasmid, pJEP5, was excised with BamHI and
ligated into the BamHI site of pPR34 (Rodriguez andBS-C-1, CV-1, HeLa D980R, RK-13, TK0143B, and Vero
Smith, 1990) to form pJEP7.cells were grown in minimum essential medium (Gibco)
supplemented with 10% fetal bovine serum (FBS). The
Northern analysissources of viruses are as described (Alcamı´ and Smith,
1992). Vaccinia virus strain WR and recombinants derived Northern analysis and preparation of the 32P-labeled
from it were grown in BS-C-1 cells. Working stocks of probe were carried out as described previously (Parkin-
virus were prepared by dounce homogenization of in- son and Smith, 1994). The probe was produced using an
fected cell extracts, removal of nuclei by centrifugation, M13 clone containing vaccinia virus DNA entirely from
and sedimentation of virus in the supernatant through a within the A38L ORF and of coding strand polarity.
sucrose cushion (Mackett et al., 1985). Virus infectivity
was titrated by plaque assay on BS-C-1 cells (Mackett Production of an antiserum to A38L
et al., 1985).
A 20-amino-acid synthetic peptide which corres-
ponded to amino acids 34–53 of the A38L ORF was usedPlasmid constructions
for the production of a rabbit polyclonal anti-A38L serum.
This amino acid sequence was from the putative extra-The vaccinia virus (WR) A38L gene was obtained from
cellular IgV-like domain of the A38L ORF and was chosena plasmid containing the vaccinia WR Sal I L fragment
for its predicted antigenicity using GCG program plot-(6.3 kb) cloned at the Sal I site of pUC13 (Smith et al.,
structure (Devereux et al., 1984). New Zealand White rab-1991) by digestion with AvaII and ligation of a 2003-bp
bits were initially immunized with 1 mg and boosted fivefragment containing the A38L gene into the HincII site
times with 0.5 mg of the peptides at approximately 3.5-,of pUC13, forming pJEP1. To remove an internal 596-bp
5.5-, 7-, 9-, and 6.5-week intervals. Serum used was de-fragment of the A38L ORF, pJEP1 was digested with SpeI,
rived from blood collected 10 days after the fifth boost.made blunt-ended with Klenow enzyme, and further di-
gested with HincII. After religation, the resulting plasmid,
In vitro transcription and translationpJEP11, contained 214 nucleotides of the 5* end and 22
nucleotides of the 3* end of the A38L ORF. Next the
For in vitro translation the designated gene was cloned
Escherichia coli guanine phosphoribosyl transferase
into the pGEM3Z vector (Promega) under control of the
(Ecogpt) gene, under the control of the vaccinia virus 7.5-
T7 promoter. The resultant vectors were then linearized
kDa promoter (Boyle and Coupar, 1988) was inserted into
downstream of the coding region to facilitate production
the unique EcoRI site of pJEP11 distal to other vaccinia
of run-off transcripts. Transcription and translation reac-
virus sequences, generating pJEP13. pJEP13 was de-
tions were performed using Promega riboprobe and re-
signed for the construction of a recombinant virus lacking
ticulocyte lysate kits, respectively. Dog pancreatic micro-
the A38L gene by transient dominant selection (Falkner
somes were also obtained from Promega.
and Moss, 1988), and as A38L overlaps the potential
coding and promoter regions of the upstream gene, Posttranslational analyses of the A38L protein in vitro
A39R, the region removed from A38L was designed so
as not to interfere with the expression of the A39R gene. Following cotranslational translocation of the A38L
protein in vitro, membranes were harvested by centrifu-A plasmid, pJEP7, designed for the construction of a virus
(IndA38L) containing an inducible copy of the A38L gene gation at 13,000 g at 47C for 30 min. Membranes were
then resuspended in phosphate-buffered saline (PBS)and lacking the endogenous A38L gene, was also pro-
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and the suspension was divided equally into three parts. Virus construction
These were incubated on ice for 30 min in PBS alone,
A vaccinia virus deletion mutant lacking 72% of thePBS containing 0.1 mg/ml proteinase K, or PBS con-
A38L ORF was constructed by transient dominant selec-taining 0.1 mg/ml proteinase K and 0.1% Triton X-100.
tion (Falkner and Moss, 1988) using the Ecogpt gene asPhenylmethylsulfonyl fluoride was then added to a final
the selectable marker (Boyle and Coupar, 1988; Falknerconcentration of 5 mM and samples were incubated for
and Moss, 1988). Wild-type virus-infected CV-1 cells were5 min at 507C in 40 ml of protein sample buffer (Laemmli,
transfected with calcium phosphate-precipitated pJEP131970) before being analyzed by sodium dodecyl sulfate–
DNA and recombinant viruses were selected as pre-polyacrylamide gel electrophoresis (SDS–PAGE). Tryp-
viously described for the A36R gene (Parkinson andsinization of membrane-associated A38L protein was
Smith, 1994). Normal (WTA38L) and small (DA38L) virusperformed by isolating the membrane fraction from an in
plaques were plaque purified and the virus isolates werevitro translation reaction, as described above, and then
amplified and screened by PCR and Southern blot analy-resuspending the membrane pellets in either PBS or PBS
sis (Southern, 1975) to determine the structure of theircontaining 1 mg/ml trypsin. Samples were incubated at
genomes. To reinsert the A38L gene into the endogenous377C for 1 hr before adding trypsin inhibitor to a final
locus of DA38L, CV-1 cells were infected with DA38Lconcentration of 1 mg/ml. Endo H treatment of mem-
(0.05 PFU/cell) and transfected with pJEP1 DNA (con-brane-associated A38L protein was performed according
taining the whole A38L gene). Progeny virus harvestedto the instructions of the manufacturer (Promega).
2 days postinfection was plated onto BS-C-1 monolayers
and large plaques (RA38L) were picked 3 days later.
Immunoprecipitation of in vitro-translated proteins These were then plaque purified twice more and
screened by PCR and Southern blot analysis to deter-
Following in vitro translation, membranes were har- mine their genomic structures. A vaccinia recombinant
vested from the reaction mixture by sedimentation at containing a single inducible A38L gene was constructed
13,000 g at 47C for 30 min. Membrane pellets were resus- as described previously (Wilcock and Smith, 1994). WR-
pended in 1 ml of RIPA buffer (150 mM NaCl, 0.5% deoxy- infected TK0143B cells were transfected with pJEP7 DNA
cholic acid, 1.0% NP-40, 1.0% SDS, 50 mM Tris–HCl, pH and a TK0 recombinant virus (InterIndA38L), containing
7.5), vortexed, and incubated on ice for 10 min. Insoluble an inducible and endogenous copy of A38L, was se-
material was removed by centrifugation at 10,000 g for lected and plaque purified in the presence of 25 mg/ml
10 min. The supernatant fraction was then added to a bromodeoxyuridine on TK0143B cells. Virus isolates
further 4 ml of RIPA buffer together with 5 ml of the de- were amplified and screened by PCR and Southern blot
sired polyclonal antiserum. Samples were then incu- analysis. The endogenous A38L gene was then deleted
bated at 47C for 18 hr after which 7.5 mg of protein by transient dominant selection (as described above), in
A–Sepharose (Sigma) was added before returning the the presence of 5 mM IPTG, using pJEP13 DNA. The final
samples to 47C for a further 2 hr. Finally, the protein A – inducible A38L virus (IndA38L) contained a single IPTG-
Sepharose beads were washed three times in RIPA inducible copy of the A38L gene in the TK locus.
buffer before being incubated at 507C for 5 min in 50 ml
Screening of recombinant virus genomesof protein sample buffer and the eluted proteins were
analyzed by SDS–PAGE.
PCR analysis. The viral genomic structure distal to the
A38L gene locus was determined by PCR using DNA
Immunoprecipitation of proteins synthesised in vivo extracted from infected cells or virus cores (Esposito et
al., 1981) as templates and oligonucleotide primers flank-
BS-C-1 cells were infected with either WR, DA38L, or ing the 3* end of the A40R gene (5*CGGGCATATGAA-
IndA38L viruses (see below) at 5 plaque forming units CAAACATAAGACA) and complementary to an internal
(PFU) per cell. Mock-infected cells were processed in region of the A38L gene (5*GTCTAGCACTAGTATGCC).
parallel. After 12 hr the cells were starved for 30 min in DNA was denatured at 957C for 5 min followed by 25
Met0 and Cys0 medium before being labeled using 100 cycles of denaturation at 947C for 1 min, annealing at
mCi of Trans-Label ([35S]Met and [35S]Cys) (Amersham) 507C for 2 min, and extension at 727C for 3 min, before
for 1 hr. Cells were then washed three times in PBS a final elongation period of 5 min at 727C.
and resuspended in 1 ml of RIPA buffer. Samples were Southern blot analysis. Vaccinia virus DNA extracted
vortexed and incubated on ice for 10 min before insoluble from virus cores was digested with AvaII and the frag-
material was removed by centrifugation at 10,000 g for 10 ments were resolved on a 1% agarose gel before being
min. Labeled A38L protein was then immunoprecipitated transferred to nylon membrane. Blots were probed with
using anti-A38L peptide serum as described above for fluorescein-labeled DNA probes: (a) a 278-bp DraI–ClaI
proteins expressed in vitro. Samples were then analyzed fragment representing DNA deleted from the A38L ORF
in DA38L, (b) a 871-bp BamHI fragment isolated fromby SDS–PAGE.
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pJEP5 containing the entire A38L gene, and (c) the com- son and Moss, 1989), are also present at positions 6–
10, 10–14, and 31–35 nucleotides upstream of the ORF.plete A36R gene obtained by PCR amplification as de-
scribed (Parkinson and Smith, 1994). Labeling of probes These features suggest that the protein might be ex-
pressed late during infection. Additionally, there is a 99-and subsequent blot detection was performed using a
random prime labeling and detection ECL system (Amer- bp overlap between the predicted 5* ends of the A38L
ORF and the upstream A39R ORF, and both ORFs havesham) as instructed by the manufacturer.
typical vaccinia codon usage as determined using pro-
Cesium chloride (CsCl) gradient analysis of IMV gram NIP (Staden, 1990). The transcription of A39R is
and EEV also predicted to be late and thus it is possible that A38L
and A39R RNAs with complementary 5* ends will beTo measure the levels of IMV and EEV, infected RK-
produced during the late phase of infection.13 cells were isotopically labeled with 25 mCi/ml of 35S-
To determine the temporal transcriptional regulationTrans-Label (ICN Flow) containing a mixture of [35S]-
of the A38L gene, RNA was extracted from infected cellsmethionine and [35S]cysteine from 8 to 24 hr postinfection
early or late during infection and used in Northern blot-(hpi). IMV and EEV were then purified and separated on
ting and S1 nuclease protection experiments (data notCsCl density gradients as described (Payne and Norrby,
shown). Northern blotting detected minor heterogeneous1976) and the density and radioactivity of the gradient
late transcripts (characteristic of late vaccinia virusfractions was determined by refractometry and scintilla-
mRNAs) but no early mRNA. The late transcripts couldtion counting, respectively. Peak fractions containing ei-
have initiated at the potential late transcription initiationther IMV or EEV were pooled and their infectivity titers
sites 5* to the A38L ORF, or at late promoters furtherwere determined by plaque assay.
upstream, and represent readthrough transcripts. No
RNA start site was found within 670 nucleotides up-Virulence assay in mice
stream of the AUG by S1 nuclease protection analysis.
Five- to six-week-old female BALB/c mice were anes-
thetized and infected intranasally with 104, 105, 106, or In vitro analyses of the A38L protein
107 PFU of virus diluted in 20 ml of PBS. Mice were
A rabbit reticulocyte translation system was used toweighed daily and monitored for signs of illness or death.
analyze the size, membrane topology, and posttransla-Animals that had lost greater than 30% of their body
tional modification of the A38L protein. RNA encodingweight were sacrificed.
the A38L protein was generated in vitro as described
under Materials and Methods and transcripts were trans-
RESULTS
lated in the presence or absence of canine pancreatic
microsomes (Fig. 2). In the absence of membranes (Fig.The sequence of the WR A38L gene predicts a primary
2, lane 1) the A38L translation product aggregated as atranslation product of 277 amino acids, Mr 31.6K, with a
large complex which did not enter the running gel, andhydrophobic N-terminal sequence of 17 amino acids,
was not observed when translations were performed inwhich may function as a signal peptide (Fig. 1A). This
the absence of A38L-specific transcript (data not shown).sequence is followed by a relatively charged hydrophilic
However, when canine pancreatic microsomes were in-region with two potential sites for the attachment of N-
cluded in the translation reaction a Mr 33-kDa translationlinked carbohydrate and sequence similarity to IgV-like
product was produced (Fig. 2, lane 2). The protein wasdomains of the IgSF. The remaining 60% of the protein
membrane-associated because it pelleted with the mem-is predominantly hydrophobic, with five putative mem-
brane fraction during centrifugation (lanes 5 and 6). Asbrane-spanning domains. The division of the protein into
a control the A34R integral membrane protein of EEVa hydrophilic N-terminal IgV-like domain and hydropho-
(Duncan and Smith, 1992) was expressed in parallel andbic C-terminal domain is clearly evident in the hydropho-
also pelleted preferentially with the membrane fractionbicity profile of the predicted A38L protein (Fig. 1B). It
(lanes 3 and 4). The A38L protein translated without mi-seems likely, therefore, that the protein encoded by gene
crosomes did not sediment under these conditions (dataA38L would be membrane-associated with amino acid
not shown).sequences exposed on both sides of the membrane
(Fig. 3C).
Posttranslational modification and membrane
topology of the A38L proteinTranscriptional analysis
The A38L gene contains four early transcription termi- To define the membrane topology of the A38L protein
we investigated whether the putative N-linked glycosyla-nation motifs, TTTTTNT (Yuen and Moss, 1987), one
within the coding region, positions 520–526, and three tion sites within the IgV-like N-terminal portion of the
protein were glycosylated after association with mem-downstream of the A38L ORF, in an intergenic region
(Fig. 1A). Late transcription initiation sites, TAAAT (Davi- branes and how much of the membrane-associated pro-
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FIG. 1. Features of the A38L gene. (A) The nucleotide and deduced amino acid sequence of the A38L ORF. Potential early transcriptional
termination signals (T5NT) and late transcriptional initiation sites (TA3T/TA4T) of A38L are underlined. Underlined amino acids represent a 17-amino-
acid N-terminal hydrophobic sequence, five putative hydrophobic transmembrane-spanning domains, and two potential N-linked glycosylation sites
(N-X-S/T) in the deduced A38L polypeptide sequence. The plus sign (/) indicates the 5* end of the upstream gene A39R. The cysteine residues
presumed to form a disulfide bond within the IgV-like domain are indicated by arrows. [The domains of the amino acid sequence are taken from
(Lindberg et al., 1993)]. (B) Hydrophobicity profile of the A38L protein. The positive and negative values on the ordinate indicate sequences of
hydrophobic or hydrophilic nature, respectively. Positions of the putative N-terminal signal peptide and membrane-spanning domains are overlined
and underlined, respectively, and the arrows demarcate the region with sequence similarity to IgV domains.
tein was protected from digestion by external proteases. 8, shows that the relative mobility of the A38L protein
increased after treatment with Endo H demonstrating thatAs the A38L protein aggregated when translation reac-
tions were performed in the absence of membranes it the protein is posttranslationally glycosylated. Therefore,
the N-terminal IgV-like domain of the molecule is insertedwas impossible to tell by comparative mobility during
SDS–PAGE whether or not the protein became glycosyl- into the luminal side of the microsome.
This result was confirmed by incubating membranesated in the presence of membranes. Consequently Endo
H was used to remove any N-linked carbohydrate added containing the A38L protein with proteinase K to deter-
mine what proportion of the A38L protein remained ex-after association with membranes. Figure 2, lanes 7 and
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and second, the yeast a-factor, which is a soluble luminal
protein that should not be affected by addition of external
proteases. Figure 3A shows that a-factor remained undi-
gested in the presence of protease (lanes 4 and 5), show-
ing that the microsomal vesicles were intact, while A34R
showed a slight increase in mobility after protease treat-
ment consistent with loss of the short cytoplasmic tail
(lanes 1 and 2). Under these conditions the relative mobil-
ity of the A38L protein was unaffected (lanes 7 and 8).
FIG. 2. In vitro translation of the A38L protein and analysis of post- This demonstrated that most of the A38L protein is not
translational glycosylation. RNA transcripts encoding either A38L or exposed on the outer surface of the microsome although
A34R proteins were generated in vitro as described under Materials
there may be external domains which are exposed butand Methods. A38L protein was then translated in vitro in the absence
sterically protected from efficient digestion. Interestingly,(lane 1) or presence (lanes 2 and 5–8) of canine pancreatic micro-
somes. Soluble and membrane components of the in vitro translation we found that all of the aggregated form of the A38L
reaction containing either A34R (lanes 3 and 4) or A38L (lanes 5 and protein, which did not enter the gel, was removed by
6) were separated into supernatant (S) and pellet (P) fractions by centrif- proteolysis, indicating that this population was still out-
ugation at 13,000 g and 47C for 30 min. A38L protein that pelleted with
side the microsome and probably represents misfoldedmicrosomes was incubated with (lane 7) or without (lane 8) Endo H
protein unable to attain correct membrane insertionas described under Materials and Methods. All samples were then
resolved by SDS–PAGE (15% gel) and an autoradiograph was pre- (lanes 7 and 8). The small amount of a 19-kDa fragment
pared. A38L and dgA38L denote the glycosylated and deglycosylated was thought to derive from this aggregated material dur-
forms of the protein, respectively. ing proteolysis (lane 8). All three proteins were digested
by protease K after detergent lysis of microsomes (lanes
posed on the outside surface of the microsomes. To 3, 6, and 9).
assess microsomal integrity two control proteins were A more detailed analysis of membrane topology of the
used: first, the vaccinia A34R protein, which is a type II A38L protein was performed using trypsin. Figure 3B
membrane protein with a short cytoplasmic tail (Duncan shows that trypsinization of membrane-associated A38L
protein generated a 23-kDa fragment which is consistentand Smith, 1992) that should be cleaved by proteolysis;
FIG. 3. Protease treatment of membrane-associated A38L protein. Yeast a-factor and the vaccinia proteins A34R and A38L were individually
translated in vitro in the presence of canine pancreatic microsomes. Membranes from each translation reaction were then harvested by centrifugation
at 13,000 g and 47C for 30 min. (A) In each case the membrane pellet was divided into three equal parts, one of which was incubated in the
absence of either proteinase K or Triton X-100 (lanes 1, 4, and 7), a second was incubated with proteinase K (0.1 mg/ml) but not Triton X-100 (lanes
2, 5, and 8), and a third was incubated with both proteinase K (0.1 mg/ml) and Triton X-100 (0.1% v/v) (lanes 3, 6, and 9). (B) The results of incubating
membranes containing the A38L protein in identical buffers (/) or (0) 1 mg/ml trypsin. The asterisk indicates the position of a 23-kDa fragment
generated by trypsinization. All samples were then resolved by SDS–PAGE (15% gel) and an autoradiograph was prepared. (C) Schematic representa-
tion of the membrane topology of the A38L protein.
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previously infected with the WR virus immunoprecipitated
the vaccinia virus proteins A34R and A38L but not the
yeast a-factor (Fig. 4A, lanes 7–9). This observation dem-
onstrates that the A38L protein is expressed during WR
virus infection.
Identification of the A38L protein in vivo
To identify the A38L protein in infected cells, BS-C-1
cells were mock-infected or infected with a plaque-puri-
fied WT virus (WTA38L), a virus in which the A38L gene
had been deleted (DA38L), or a virus in which the A38L
gene had been placed under IPTG-inducible control of a
strong late vaccinia promoter (IndA38L) and cell extracts
were immunoprecipitated with anti-A38L peptide serum.
A 33-kDa band, similar to that observed after in vitro
translation in the presence of microsomes (Fig. 3), was
detected in extracts from cells infected with IndA38L vi-
FIG. 4. Immunoprecipitation of the A38L protein. (A) Immunoprecipi-
rus or WTA38L (Fig. 4B, lanes 4 and 2), but not fromtation of in vitro-translated A34R, A38L, and yeast a-factor proteins.
either uninfected cells or cells infected with the DA38LYeast a-factor (lanes 2, 5, and 8) and the vaccinia virus proteins A34R
(lanes 1, 4, and 7) and A38L (lanes 3, 6, and 9) were translated in vitro deletion virus (Fig. 4B, lanes 1 and 3). The greater amount
in the presence of canine pancreatic microsomes. Membranes were of A38L protein seen in IndA38L-infected cells reflects
recovered from translation reactions by centrifugation at 13,000 g and the use of the strong 4b promoter and indicates that the
47C for 30 min and each pellet was resuspended in 100 ml of PBS.
A38L promoter is relatively weak in comparison. BecauseThirty-microliter-aliquots were then immunoprecipitated with either an
the A38L protein detected within infected cells corre-anti-A38L peptide serum (lanes 4–6) or serum derived from a rabbit
previously infected with WR virus (lanes 7–9). In addition a 5-ml sample sponds to the glycosylated form of the protein made in
of the resuspended membranes was not immunoprecipitated but was vitro, we conclude that the A38L protein is made as a
diluted in SDS–protein buffer (lanes 1–3). All samples were resolved glycoprotein which is expressed at low levels during WR
by SDS–PAGE (15% gel) and an autoradiograph was prepared. (B)
virus infection.Detection of the A38L protein expressed in virus-infected cells. BS-C-
The physical location of the A38L protein in infected1 cells were either mock-infected (lane 1) or infected with WR (lane 2),
DA38L (lane 3), or IndA38L in the presence of 5 mM IPTG (lane 4), cells was not easy to determine because of the low abun-
and then proteins were metabolically labeled and immunoprecipitated dance of the protein and the poor nature of the available
as described under Materials and Methods using 10 ml of anti-A38L antibody, but the fact that it is membrane-associated
peptide serum. The dried gel was exposed against film for 4 months.
when translated in vitro suggests that it would also be
an integral membrane protein in infected cells. Whether
this is at the cell surface or an internal membrane re-with the protein being cleaved at trypsin-sensitive sites
mains to be determined. The possible presence of thein the cytoplasmic tail and within loop 3 (Fig. 3C). These
A38L protein in IMV or EEV was investigated by purifica-data are consonant with the A38L protein having a con-
tion of IMV and EEV, biotinylation of the surface proteins,formation in which the IgV-like N-terminal domain of the
immunoprecipitation with anti-A38L serum, transfer to ni-protein is inside the lumen of the microsome. The data
trocellulose, and incubation with strepavidin followed byalso suggest that, after the IgV-like domain, the A38L
ECL reagents. Using this technique the A38L protein wasprotein has five transmembrane regions and that loops
not detected in either IMV or EEV. In contrast, an antibody2 and 4 are on the luminal side of the microsome while
to the vaccinia virus 14K protein (present on the IMVloops 1 and 3 and the C-terminal tail are exposed on the
surface) (Rodriguez et al., 1985) or to the gp42 proteinoutside of the microsome in vitro (Fig. 3C).
(present on the EEV surface) (Engelstad et al., 1992),
Characterization of a polyclonal antiserum specific for detected 14K or gp42 in IMV and EEV, respectively (data
the A38L protein not shown). We conclude that the A38L might not be a
virion protein, but given the poor nature of the A38L anti-
To confirm the identity of the in vitro translation prod-
body its possible virion location is not excluded. Anti-
ucts and identify the A38L protein in vivo, an antiserum
A38L serum did not neutralize IMV or EEV infectivity (data
was raised against an A38L peptide representing amino
not shown).
acids 34–53 from the IgV-like N-terminal domain (Materi-
als and Methods). The specificity of this antiserum was Recombinant WR virus construction and analysis
confirmed by its ability to immunoprecipitate only the
A38L protein and not A34R or yeast a-factor (Fig. 4A, To analyze the function of the A38L ORF in the vaccinia
virus life cycle, a recombinant virus lacking 72% of thelanes 4–6). In a similar experiment, serum from a rabbit
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FIG. 5. Southern blot analysis of virus genomes. DNA was extracted from cores of WR, WTA38L (WT), DA38L (D), and RA38L (R) viruses, digested
with AvaII, separated by electrophoresis (1% agarose gel), and transferred to nylon Hybond N filters. Filters were probed with (A) a 278-bp DraI –
ClaI fragment isolated from the A38L gene in pJEP5, (B) a 871-bp BamHI fragment isolated from pJEP5 containing the entire A38L gene, or (C) the
complete A36R gene obtained by PCR amplification using oligonucleotides 5* and 3* to A36R. Molecular weight markers (M) and the sizes of
individual bands are shown in kilobases.
ORF (DA38L) was constructed by transient dominant se- Southern blotting (Fig. 5) and PCR (data not shown). For
Southern blot analysis, the DNAs were digested withlection (Materials and Methods). Both DA38L and wild-
type (WT38L) plaques were isolated. As DA38L and AvaII and a 2-kb fragment, spanning the A38L gene, was
identified in WR DNA by a probe containing DNA fromWTA38L were derived from the same MPA-resistant in-
termediate virus after its resolution, WTA38L is geneti- the region deleted in DA38L (Fig. 5A) or the whole A38L
gene (Fig. 5B). These probes also detected fragments ofcally closer to DA38L than uncloned WR. To eliminate
the possibility that any phenotypic differences between this size in viruses WTA38L and RA38L, but either failed
to detect any fragments in DA38L (Fig. 5A) or identifiedWTA38L and DA38L were due to another mutation ac-
quired by DA38L during its production, a revertant virus a smaller A38L-specific fragment of 1.4 kb in DA38L
(Fig. 5B). These analyses showed that a region of the(RA38L) with the A38L gene restored to its endogenous
locus was constructed by marker rescue, exploiting the expected size had been removed from the A38L gene in
DA38L. The genomic structure to the left of the A38Lsmall plaque phenotype of DA38L as the marker (see
below). gene was investigated using an A36R probe. This de-
tected the same 1.58-kb AvaII restriction fragment in allDNA was extracted from uncloned WR, WTA38L,
DA38L, and RA38L viruses, and the genomic structures four viruses (Fig. 5C), indicating that no genomic alter-
ations or rearrangement had occurred to the left of A38L.of the recombinant virus genomes were analyzed by
FIG. 6. Plaque phenotype of DA38L. WTA38L, DA38L, and RA38L viruses were plated onto monolayers of BS-C-1 cells and overlaid with MEM
supplemented with 2.5% FBS and 1.5% carboxymethyl cellulose for 3 days, before being stained with 0.1% crystal violet in 15% ethanol.
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FIG. 7. Biochemical measurements of IMV and EEV formation. RK-13 cells were infected with viruses WTA38L, DA38L, or RA38L at 10 PFU/cell.
After 8 hr the cells were labeled with 35S-Trans-Label, as described under Materials and Methods. At 24 hpi the virus in the culture supernatant
(media) or cells was purified by CsCl density gradient centrifugation, and the radioactivity and density of the gradient fractions were determined.
The arrows indicate the densities at which either EEV or IMV virions band in these gradients. Peak fractions from each IMV and EEV gradient were
pooled, and the infectivity titers were determined by plaque assay on BS-C-1 cells. The total radioactivity and infectivity of the peak fractions are
indicated below. Also indicated are the ratios of radioactivity and infectivity between DA38L and WTA38L or DA38L and RA38L viruses.
To analyze the structure to the right of A38L, PCR analysis virus spread. To distinguish between these possibilities
the production of IMV and EEV was investigated by in-was performed using oligonucleotides flanking the 3*
end of the A40R ORF and complementary to a 5* internal fectivity and biochemical assays. Single-step growth
curve analyses after a high multiplicity infection (m.o.i.)region of A38L. A PCR product of 1.95 kb was produced
for all the viruses, as expected. The absence of the with WTA38L, DA38L, and RA38L showed that the yields
of infectious virus were similar for all viruses at 24 hpiEcogpt gene was also confirmed with oligonucleotides
to the 5* and 3* ends of the Ecogpt gene. Collectively (data not shown). This was more accurately investigated
by infecting RK-13 cells at high m.o.i., labeling the cellsthese data showed that the viruses have the predicted
genomic structures. with [35S]methionine/[35S]cysteine at 8 hpi, and separat-
ing IMV and EEV, harvested at 24 hpi, on CsCl density
Loss of the A38L gene causes a slight reduction in gradients. The amounts of both 35S-labeled IMV and 35S-
plaque size labeled EEV were indistinguishable for the three viruses
and the infectivities of the peak fractions, measured byDuring the isolation of DA38L it was evident that this
plaque assay, were also similar (Fig. 7). These data indi-virus produced a slightly smaller plaque than wild-type
cate that the A38L protein does not play an important, ifvirus. This reduced plaque size on BS-C-1 cells was due
any, role in the formation or infectivity of IMV and EEVto loss of A38L rather than some other mutation, since
in cell culture. It follows that the reduced plaque size isthe plaque size was restored to normal by reinsertion of
probably due to reduced virus spread.the A38L gene (Fig. 6). Similar results were obtained on
Vero, CV-1, RK-13, TK0143, and D980R cells (data not
Virulence of DA38L in vivoshown), indicating that deletion of A38L does not lead to
a host range restriction on any of the monkey, rabbit, or Despite the failure to detect abundant levels of the
human cell lines tested. A38L protein, the effect of removal of the A38L gene on
plaque size indicates that this gene plays some role in
IMV and EEV production by DA38L
the virus life cycle. This suggested that A38L might influ-
ence virus virulence. The virulence of DA38L comparedThe consequence of deletion of A38L on plaque size
could be due to a reduction in virus yield or diminished to WTA38L and RA38L viruses was therefore investigated
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FIG. 8. Percentage weight change of female BALB/c mice infected with WTA38L, DA38L, or RA38L. Groups of five 5- to 6-week-old mice were
infected intranasally with (A) 107, (B) 106, (C) 105, or (D) 104 PFU of the indicated viruses, or were uninfected (control), and then individually weighed
daily. The mean weight of each group of mice was compared with the mean weight of the same group on the day of infection (Day 0) and expressed
as the percentage change from Day 0.
in a murine intranasal model. Virulence was assessed containing microsomes. First, Endo H digestion showed
by mortality (data not shown), weight loss (Fig. 8), and that either or both of the two putative N-linked glycosyla-
signs of illness (piloerection, arched back, and reduced tion sites within the IgV-like domain of the protein were
mobility). Animals infected with each virus all suffered glycosylated, and therefore this domain must be inserted
substantial weight loss, and either died or were sacri- into the lumen of the microsome. Second, tryptic diges-
ficed at doses of 105, 106, and 107 PFU. At the lowest tion of membrane-associated A38L protein generated a
dose (104 PFU), some mice died after infection with each 23-kDa fragment which is consistent with loops 1 and 3
virus but the numbers were not significantly different. of the hydrophobic region of the protein being exposed
These data show that, at least in this model, the A38L on the outside of microsomes and loops 2 and 4 being
gene does not contribute to virus virulence. in the lumen. This demonstrated that the A38L protein is
orientated in the membrane in such a way as to have
an exoplasmic IgV-like N-terminal domain and five C-DISCUSSION
terminal transmembrane domains which pass sequen-
tially in and out of the cell terminating in a short cyto-In this paper we have identified and characterized the
plasmic C-terminal tail.protein encoded by gene A38L of vaccinia virus strain
The vaccinia virus A38L protein and the mammalianWR. These data show that the A38L gene encodes a 33-
IAP thus share 28% amino acid identity and a strikingkDa transmembrane glycoprotein which is expressed at
conservation of tertiary structure and membrane topol-a low level in infected cells in culture (Fig. 4B) and also
ogy. It will be interesting, therefore, to determine whetherduring in vivo infection (Fig. 4A). The protein has an N-
the vaccinia A38L protein possesses any of the functionalterminal IgV-like domain followed by five membrane-
properties reported for IAP. For example, IAP associatesspanning regions. The membrane topology of the A38L
protein was analyzed in an in vitro translation system with the b3 subunit of the avb3 integrin complex (Brown
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et al., 1990) and mediates calcium influx into cells during mode of action of a novel group of multiple membrane-
spanning, IgSF members.cytoadhesion possibly by functioning as a calcium pore
(Schwartz et al., 1993). However, the low level of se-
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